Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 114   

Articles published

JNJ 100.14 -2.24 (-2.19%)
price chart
Mother brought to tears hearing Johnson & Johnson's Risperdal tactics
Pledger had just finished a full day of listening to her attorney, Thomas Kline, and former U.S. Food and Drug Administration commissioner Dr.
Johnson & Johnson Accused Of Adolescent Risperdal Risks  Bidness ETC
J&J Slams Ex-FDA Chief in Male Breast-Growth Case  Bloomberg
Johnson & Johnson Will Make Clinical Data Available to Outside Researchers
The health care giant Johnson & Johnson has agreed to make detailed clinical trial data on its medical devices and diagnostic tests available to outside researchers through a collaboration with Yale University, making it the first large device ...
Johnson & Johnson Sends More Data to Yale for Researchers  Bloomberg
One Way Johnson & Johnson Can Unlock At Least 25% Upside
Johnson & Johnson (NYSE:JNJ) definitely falls in the latter, a company with a near $285 billion market capitalization trading with a P/E ratio of 17 and near flat top line growth.
Johnson & Johnson beats fourth quarter estimates
Shares of Johnson & Johnson (JNJ) dropped 2.6% to $101.29 Tuesday after posting better-than expected quarterly earnings but a 0.6% drop in sales.
Johnson & Johnson Tops 4Q Earnings Expectations  ABC News
Johnson & Johnson Facing Headwinds From A Stronger Dollar  Forbes
Johnson & Johnson's $7.2 billion claim against Boston Scientific now with US ...
NEW YORK (Reuters) - For more than eight years, Johnson & Johnson (JNJ.N) has pursued billions of dollars in damages against Boston Scientific Corp (BSX.
Johnson & Johnson (JNJ) Claims It Is Owed $7.2 Billion By Boston Scientific  Bidness ETC
This Stock Could Become the Next Johnson & Johnson
There's little debate that healthcare goliath Johnson & Johnson (NYSE: JNJ ) has become the de facto gold standard among healthcare companies.
Investors Buy Shares of Johnson & Johnson on Weakness (JNJ)  Dakota Financial News
Johnson & Johnson Given "AAA" Credit Rating by Morningstar (JNJ)  Ticker Report
Ebola vaccine on its way to West Africa, Johnson & Johnson says
NEW BRUNSWICK - Johnson & Johnson has started to administer the first Ebola vaccine doses to volunteers, as part of a clinical trial which could reach millions over the course of this year, the New Jersey-based company announced today.
New Jersey-Based Johnson & Johnson Begins Testing Ebola Vaccine  CBS Local
Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola ...  MarketWatch
Related articles »  
FIFA loses World Cup sponsors Castrol, Continental, Johnson & Johnson
Oil manufacturers Castrol, tyre and car parts business Continental and healthcare company Johnson & Johnson have each chosen not to extend deals with FIFA.
Fifa loses three key sponsors as Castrol, Continental and Johnson & ...  Telegraph.co.uk
Fifa sponsors Castrol, Continental Tyres and Johnson & Johnson join Sony ...  International Business Times UK
Johnson & Johnson Seeks Patent on Electronic Contact Lenses
As we've seen a lot recently, Johnson & Johnson patent applications have been focused on the development of electronic components for contact lenses.
Interesting February Stock Options for Johnson & Johnson
So unless Johnson & Johnson sees its shares fall 3% and the contract is exercised (resulting in a cost basis of $100.70 per share before broker commissions, subtracting the $1.30 from $102), the only upside to the put seller is from collecting that ...